InChI=1S/C21H31NO7S/c22- 16(21(28) 29) 15- 30- 18(17(23) 11- 10- 14- 20(26) 27) 12- 8- 6- 4- 2- 1- 3- 5- 7- 9- 13- 19(24) 25/h1- 2,4- 8,12,16- 18,23H,3,9- 11,13- 15,22H2,(H,24,25) (H,26,27) (H,28,29) /b2- 1- ,6- 4+,7- 5- ,12- 8+/t16- ,17- ,18+/m0/s1 |
OXCSBZDIZXLXRX-AVYHYKEVSA-N |
[H][C@](N)(CS[C@H](\C=C\C=C\C=C/C\C=C/CCC(O)=O)[C@@H](O)CCCC(O)=O)C(O)=O |
|
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
|
|
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
|
|
View more via ChEBI Ontology
(4Z,7Z,9E,11E,13R,14S)- 13- (L- cystein- S- yl)- 14- hydroxyoctadeca- 4,7,9,11- tetraenedioic acid
|
(4Z,7Z,9E,11E,13R,14S)- 13- {[(2R)- 2- amino- 2- carboxyethyl]sulfanyl}- 14- hydroxyoctadeca- 4,7,9,11- tetraenedioic acid
|
18-carboxy-19,20-dinor-LTE4
|
ChEBI
|
18-carboxy-19,20-dinor-LTE4
|
ChEBI
|
18-carboxy-dinor-leukotriene E4
|
ChEBI
|
18-carboxy-dinor-LTE4
|
ChEBI
|
18-carboxy-dinor-LTE4
|
HMDB
|
4588801
|
Reaxys Registry Number
|
Reaxys
|
2174886
|
PubMed citation
|
Europe PMC
|
7663693
|
PubMed citation
|
Europe PMC
|
8484009
|
PubMed citation
|
Europe PMC
|
|